Critical Care, King's College Hospital NHS Foundation Trust, London, UK.
School of Population Health & Environmental Sciences, King's College London, London, UK; National Institute for Health Research Comprehensive Biomedical Research Centre, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Br J Anaesth. 2021 Jul;127(1):85-101. doi: 10.1016/j.bja.2021.02.027. Epub 2021 Apr 1.
Control-arm mortality varies between acute respiratory distress syndrome (ARDS) RCTs.
We systematically reviewed ARDS RCTs that commenced recruitment after publication of the American-European Consensus (AECC) definition (MEDLINE, Embase, and Cochrane central register of controlled trials; January 1994 to October 2020). We assessed concordance of RCT inclusion criteria to ARDS consensus definitions and whether exclusion criteria are strongly or poorly justified. We estimated the proportion of between-trial difference in control-arm 28-day mortality explained by the inclusion criteria and RCT design characteristics using meta-regression.
A literature search identified 43 709 records. One hundred and fifty ARDS RCTs were included; 146/150 (97.3%) RCTs defined ARDS inclusion criteria using AECC/Berlin definitions. Deviations from consensus definitions, primarily aimed at improving ARDS diagnostic certainty, frequently related to duration of hypoxaemia (117/146; 80.1%). Exclusion criteria could be grouped by rationale for selection into strongly or poorly justified criteria. Common poorly justified exclusions included pregnancy related, age, and comorbidities (infectious/immunosuppression, hepatic, renal, and human immunodeficiency virus/acquired immunodeficiency syndrome). Control-arm 28-day mortality varied between ARDS RCTs (mean: 29.8% [95% confidence interval: 27.0-32.7%; I=88.8%; τ=0.02; P<0.01]), and differed significantly between RCTs with different Pao:FiO ratio inclusion thresholds (26.6-39.9 kPa vs <26.6 kPa; P<0.01). In a meta-regression model, inclusion criteria and RCT design characteristics accounted for 30.6% of between-trial difference (P<0.01).
In most ARDS RCTs, consensus definitions are modified to use as inclusion criteria. Between-RCT mortality differences are mostly explained by the Pao:FiO ratio threshold within the consensus definitions. An exclusion criteria framework can be applied when designing and reporting exclusion criteria in future ARDS RCTs.
急性呼吸窘迫综合征(ARDS)随机对照试验(RCT)的对照臂死亡率存在差异。
我们系统地回顾了自美国-欧洲共识(AECC)定义发布后开始招募的 ARDS RCT(MEDLINE、Embase 和 Cochrane 对照试验中心注册库;1994 年 1 月至 2020 年 10 月)。我们评估了 RCT 纳入标准与 ARDS 共识定义的一致性,以及排除标准是否有强有力或较弱的依据。我们使用荟萃回归估计对照臂 28 天死亡率的差异在多大程度上可以由纳入标准和 RCT 设计特征来解释。
文献检索共确定了 43709 条记录。纳入了 150 项 ARDS RCT;146/150(97.3%)项 RCT 使用 AECC/柏林定义来定义 ARDS 的纳入标准。与共识定义的偏差主要旨在提高 ARDS 的诊断确定性,主要与低氧血症的持续时间有关(117/146;80.1%)。排除标准可以根据选择的理由分为强有力或较弱的依据。常见的较弱依据的排除标准包括与妊娠相关、年龄和合并症(感染/免疫抑制、肝、肾和人类免疫缺陷病毒/获得性免疫缺陷综合征)。ARDS RCT 之间的对照臂 28 天死亡率存在差异(平均值:29.8%[95%置信区间:27.0-32.7%;I=88.8%;τ=0.02;P<0.01]),且使用不同的 PaO2:FiO2 比值纳入阈值的 RCT 之间差异显著(26.6-39.9 kPa 与<26.6 kPa;P<0.01)。在一个荟萃回归模型中,纳入标准和 RCT 设计特征解释了试验间差异的 30.6%(P<0.01)。
在大多数 ARDS RCT 中,共识定义被修改为纳入标准。RCT 之间死亡率的差异主要由共识定义内的 PaO2:FiO2 比值阈值来解释。在未来的 ARDS RCT 设计和报告中,可以应用排除标准框架。